PROGRAM OVERVIEW The goal of this education is to improve the hemophilia care team s abilities to integrate new and emerging hemophilia therapies into clinical practice. LEARNING OBJECTIVES Assess how emerging rebalancing treatments impact the individualization of treatment for patients with hemophilia Compare the clinical profiles of emerging rebalancing therapies for hemophilia Outline strategies for preparing treatment teams and centers for emerging rebalancing therapies in hemophilia
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- Chandler Building
Pricing
CME included with membership
| Non-member – Pharmacy SIG Journal Club (per session) | $35 |
| Member – Pharmacy SIG Journal Club (per session) | Free |
| Non-member – 2025 Fundamentals of HCT eBook | $400 |
| Member – 2025 Fundamentals of HCT eBook | $200 |
Collected from the provider’s public pages · source
Specialties served/covered
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Dermatology
- Diagnostic Radiology
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Hematology
- Medical Oncology
- Metabolic & Bariatric Surgery
- Nephrology
- Neurology
- Neuromuscular Medicine
- Nuclear Medicine
- Ophthalmology
- Pediatric Neurology
- Pulmonary Disease
- Rheumatology
- Transplant Surgery
- Urological Oncology
- Vascular Neurology
- Cardio-Vascular
- Cross-Specialty
- GI & Liver
- Medical Subspecialties
- Neurology
- Oncology & Hematology
- Pathology & Lab
- Primary care
- Radiology
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
CME access requires membership — $35–400
Free membership available for some groups
See plans on academy.isth.orgListed by the provider
- Case-based learning
- Credit · Up to 1 credit
- Members only
- Commercial Support
-
ReleasedFeb 25, 2025
-
Last day to claim creditNov 4, 2026 3 weeks left
-
PRIME Education, Inc. (PRIME®) Advancing Pediatric Hemophilia Care in the Non-Factor Era: From Factor Replacement to Rebalancing Therapies
-
CMEology +1 Advances in Hemophilia: From Joint Health to FVIII Guidelines and the Clinical Integration of Rebalancing Agents
-
Annenberg Center for Health Sciences at Eisenhower Interprofessional Care of Patients with Hemophilia
-
International Society on Thrombosis and Haemostasis +1 Gene Therapy in Hemophilia Novel and Emerging Therapies
-
International Society on Thrombosis and Haemostasis +1 Emerging Therapies in Thrombosis: Factor XI/XIa Inhibitors: Learning More: FXI/XIa Inhibitor Trials
-
International Society on Thrombosis and Haemostasis +1 Antithrombotic Strategies for Secondary Stroke Prevention: A Multidisciplinary Module
